The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
Open accessAbstract
The diagnosis of Alzheimer's disease (AD), the most common form of dementia in the general population, usually relies upon the presence of typical clinical features and structural changes on brain magnetic resonance imaging. Over the last decade, a number of biological abnormalities have been reported in the cerebrospinal fluid (CSF) of AD patients, in particular altered levels of the tau protein and the 1‐42 fragment of the amyloid precursor protein. These, however, have not yet proved sensitive and specific enough to be included in the diagnostic criteria for AD, leaving plenty of room for the search of novel biomarkers. The present study describes the analysis of CSF polypeptides by a protein‐chip array technology called surface enhanced laser desorption/ionization‐time of flight‐mass spectrometry (SELDI‐TOF‐MS). Using this approach, we detected statistically significant quantitative differences ( p < 0.05) regarding four overexpressed and one underexpressed polypeptides in the CSF of AD patients as compared to healthy controls. Four of them were further purified by strong anionic exchange chromatography (SAX) and identified by MS analysis as cystatin C, two β‐2‐microglobulin isoforms, an unknown 7.7 kDa polypeptide, and a 4.8 kDa VGF polypeptide. The combination of the five polypeptides for the diagnosis of AD allowed to classified six AD patients out of the nine included in this study and all the ten controls, which means in this small cohort that the specificity and sensitivity are 100% and 66%, respectively. This study, based on the protein‐chip array technology, demonstrates the presence in the CSF of novel potential biomarkers for AD, which may be used for the diagnosis and perhaps the assessment of the severity and progression of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Schägger, H., & von Jagow, G. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90587-2 · Cited by 11,444
Vlahou, A., Schellhammer, P. F., Mendrinos, S., Patel, K., Kondylis, F. I., Gong, L., Nasim, S., & Wright Jr., G. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64100-4 · Cited by 409
Ghiso, J., Jensson, O., & Frangione, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2974 · Cited by 332
Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients
Davidsson, P., Westman-Brinkmalm, A., Nilsson, C. L., Lindbjer, M., Paulson, L., Andreasen, N., Sj??gren, M., & Blennow, K. (2002) · Neuroreport · doi:10.1097/00001756-200204160-00015 · Cited by 200
New approaches to proteomic analysis of breast cancer
Wulfkuhle, J. D., McLean, K. C., Paweletz, C. P., Sgroi, D. C., Trock, B. J., Steeg, P. S., & Petricoin III, E. F. (2001) · PROTEOMICS · doi:10.1002/1615-9861(200110)1:10<1205::aid-prot1205>3.0.co;2-x · Cited by 198
Cohen, D. H., Feiner, H., Jensson, O., & Frangione, B. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.2.623 · Cited by 193
Codeposition of Cystatin C with Amyloid-β Protein in the Brain of Alzheimer Disease Patients
Levy, E., Sastre, M., Kumar, A., Gallo, G., Piccardo, P., Ghetti, B., & Tagliavini, F. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.1.94 · Cited by 170
Biochemical markers related to Alzheimer’s dementia in serum and cerebrospinal fluid
Teunissen, C. E., de Vente, J., Steinbusch, H. W. M., & De Bruijn, C. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00328-1 · Cited by 166
Abnormal Metabolism of γ-Trace Alkaline Microprotein
GRUBB, A. O., Jensson, Ó., Guðmundsson, G., Árnason, A., Löfberg, H., & Malm, J. (1984) · New England Journal of Medicine · doi:10.1056/nejm198412133112406 · Cited by 150
Genetic Association of a Cystatin C Gene Polymorphism With Late-Onset Alzheimer Disease
Finckh, U., von der Kammer, H., Velden, J., Michel, T., Andresen, B., Deng, A., Zhang, J., Müller-Thomsen, T., Zuchowski, K., Menzer, G., et al. (2000) · Archives of Neurology · doi:10.1001/archneur.57.11.1579 · Cited by 149
Gras, R., Müller, M., Gasteiger, E., Gay, S., Binz, P., Bienvenut, W. V., Hoogland, C., Sanchez, J., Bairoch, A., Hochstrasser, D. F., et al. (1999) · Electrophoresis · Cited by 136
Self-citationNeurotrophic factors and Alzheimer’s disease: are we focusing on the wrong molecule?
Fahnestock, M. L., Garzón, D. V., Holsinger, R. M. D., & Michalski, B. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_22 · Cited by 129
Elevation of Cystatin C in Susceptible Neurons in Alzheimer's Disease
Deng, A., Irizarry, M. C., Nitsch, R. M., Growdon, J. H., & Rebeck, G. W. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61781-6 · Cited by 128
A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease
Crawford, F., Freeman, M. J., Schinka, J. A., Abdullah, L. I., Gold, M., Hartman, R. D., Krivian, K., Morris, M. D., Richards, D., Duara, R., et al. (2000) · Neurology · doi:10.1212/wnl.55.6.763 · Cited by 110
Trani, E., Giorgi, A., Canu, N., et al. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00842.x · Cited by 108
Leung-Tack, J., Tavera, C., Gensac, M.-C., Martínez, J., & Collé, A. (1990) · Experimental Cell Research · doi:10.1016/0014-4827(90)90272-c · Cited by 91
Septo-hippocampal cholinergic and neurotrophin markers in age-induced cognitive decline
Sugaya, K., Greene, R., Personett, D. A., Robbins, M., Kent, C., Bryan, D., Skiba, E., Gallagher, M., & McKinney, M. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00072-4 · Cited by 79
Conformation of β2-Microglobulin Amyloid Fibrils Analyzed by Reduction of the Disulfide Bond
Hong, D.-P., Gozu, M., Hasegawa, K., Naiki, H., & Goto, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200188200 · Cited by 70
Alzheimer’s disease and the cystatin C gene polymorphism: an association study
Beyer, K., Lao, J. I., Gómez, M., Riutort, N., Latorre, P., Mate, J. L., & Ariza, A. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02307-2 · Cited by 64
Cerebrospinal fluid Aβ40 and Aβ42: Natural course and clinical usefulness
Shoji, M., & Kanai, M. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3306 · Cited by 40
Eagleson, K. L., Fairfull, L. D., Salton, S. R., & Levitt, P. R. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09315.2001 · Cited by 39
Cited by
Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool
Diamandis, E. P. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r400007-mcp200 · Cited by 631
β2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis
Smith, L. K., He, Y., Park, J.-S., Bieri, G., Snethlage, C. E., Lin, K., Gontier, G., Wabl, R., Plambeck, K. E., Udeochu, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3898 · Cited by 500
Broza, Y. Y., Zhou, X., Yuan, M., Qu, D., Zheng, Y., Vishinkin, R., Khatib, M., Wu, W., & Haick, H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00437 · Cited by 461
Ng, T. K. S., Ho, C. S. H., Tam, W. W. S., Kua, E. H., & Ho, R. C.-M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020257 · Cited by 413
Abdi, F., Quinn, J. F., Jankovic, J., McIntosh, M., Leverenz, J. B., Peskind, E., Nixon, R., Nutt, J., Chung, K., Zabetian, C., et al. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9309 · Cited by 384
Metadata
- Authors
- Carrette, O., Demalte, I., Scherl, A., Yalkinoglu, O., Corthals, G., Burkhard, P., Hochstrasser, D. F., & Sanchez, J.
- Venue
- PROTEOMICS
- Publisher
- Wiley
- Published
- 2003-08
- Volume
- 3
- Issue
- 8
- Pages
- 1486-1494
- ISSN
- 1615-9853 (ISSN-L)
- 1615-9861
- OpenAlex
- W1981322456
- Cited by
- 374
- References
- 23
- FWCI
- 18.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.